Treatment selection for cancer patients: Application of statistical decision theory to the treatment of advanced ovarian cancer
- 1 January 1985
- journal article
- research article
- Published by Elsevier in Journal of Chronic Diseases
- Vol. 38 (2) , 171-186
- https://doi.org/10.1016/0021-9681(85)90090-6
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- Reporting on Methods in Clinical TrialsNew England Journal of Medicine, 1982
- On the Elicitation of Preferences for Alternative TherapiesNew England Journal of Medicine, 1982
- Speech and SurvivalNew England Journal of Medicine, 1981
- The randomized clinical trial: bias in analysis.Circulation, 1981
- Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinCancer, 1981
- RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1981
- Treatment of women with disseminated or recurrent advanced ovarian cancer with melphalan alone in combination with 5-fluorouracil and dactinomycin or with the combination of cytoxan, 5-fluorouracil and dactinomycinCancer, 1980
- Fallacy of the Five-Year Survival in Lung CancerNew England Journal of Medicine, 1978
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- Use of Decision Theory in Treatment SelectionClinical Orthopaedics and Related Research, 1971